APA

Herling C. D., Klaumünzer M., Rocha C. K., Altmüller J., Thiele H., Bahlo J., Kluth S., Crispatzu G., Herling M., Schiller J., Engelke A., Tausch E., Döhner H., Fischer K., Goede V., Nürnberg P., Reinhardt H. C., Stilgenbauer S., Hallek M. & Kreuzer K. (20170803). Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy. : Blood.

Chicago

Herling Carmen Diana, Klaumünzer Marion, Rocha Cristiano Krings, Altmüller Janine, Thiele Holger, Bahlo Jasmin, Kluth Sandra, Crispatzu Giuliano, Herling Marco, Schiller Joanna, Engelke Anja, Tausch Eugen, Döhner Hartmut, Fischer Kirsten, Goede Valentin, Nürnberg Peter, Reinhardt Hans Christian, Stilgenbauer Stephan, Hallek Michael and Kreuzer Karl-Anton. 20170803. Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy. : Blood.

Harvard

Herling C. D., Klaumünzer M., Rocha C. K., Altmüller J., Thiele H., Bahlo J., Kluth S., Crispatzu G., Herling M., Schiller J., Engelke A., Tausch E., Döhner H., Fischer K., Goede V., Nürnberg P., Reinhardt H. C., Stilgenbauer S., Hallek M. and Kreuzer K. (20170803). Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy. : Blood.

MLA

Herling Carmen Diana, Klaumünzer Marion, Rocha Cristiano Krings, Altmüller Janine, Thiele Holger, Bahlo Jasmin, Kluth Sandra, Crispatzu Giuliano, Herling Marco, Schiller Joanna, Engelke Anja, Tausch Eugen, Döhner Hartmut, Fischer Kirsten, Goede Valentin, Nürnberg Peter, Reinhardt Hans Christian, Stilgenbauer Stephan, Hallek Michael and Kreuzer Karl-Anton. Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy. : Blood. 20170803.